Levonorgestrel Patent Expiration

1. Kyleena patent expiration

KYLEENA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7252839 BAYER HLTHCARE Delivery system and a manufacturing process of a delivery system
Nov, 2023

(8 months ago)

US11628088 BAYER HLTHCARE Ultrasonically detectable intrauterine system and a method for enhancing ultrasound detection
Feb, 2027

(2 years from now)

US11850182 BAYER HLTHCARE Inserter
Sep, 2029

(5 years from now)

US9615965 BAYER HLTHCARE Inserter
Sep, 2029

(5 years from now)

US10561524 BAYER HLTHCARE Inserter
Sep, 2029

(5 years from now)

US9668912 BAYER HLTHCARE Inserter
Apr, 2031

(6 years from now)

US10987244 BAYER HLTHCARE Inserter
Apr, 2031

(6 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Sep 16, 2019

Market Authorisation Date: 16 September, 2016

Treatment: A method of preventing pregnancy by providing an intrauterine system (ius), holding an inserter handle with one hand, inserting the ius into the uterus, and moving a slider in the handle to release th...

Dosage: INTRAUTERINE DEVICE

More Information on Dosage

KYLEENA family patents

Family Patents

2. Liletta patent expiration

LILETTA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11090186 MEDICINES360 Methods for using intrauterine systems and IUD insertion devices
Oct, 2033

(9 years from now)

US10028858 MEDICINES360 Intrauterine systems, IUD insertion devices, and related methods and kits therefor
Mar, 2034

(9 years from now)

US11571328 MEDICINES360 IUD insertion devices
Sep, 2040

(16 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Feb 26, 2018
New Indication(I-917) Jun 29, 2026

Market Authorisation Date: 26 February, 2015

Treatment: A method for prevention of pregnancy

Dosage: INTRAUTERINE DEVICE

More Information on Dosage

LILETTA family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Mirena patent expiration

MIRENA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5785053 BAYER HLTHCARE Inserter for the positioning of an intrauterine device
Dec, 2015

(8 years ago)

US11850182 BAYER HLTHCARE Inserter
Sep, 2029

(5 years from now)

US10561524 BAYER HLTHCARE Inserter
Sep, 2029

(5 years from now)

US9615965 BAYER HLTHCARE Inserter
Sep, 2029

(5 years from now)

US10987244 BAYER HLTHCARE Inserter
Apr, 2031

(6 years from now)

US9668912 BAYER HLTHCARE Inserter
Apr, 2031

(6 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-610) Oct 01, 2012
New Dosing Schedule(D-181) Aug 20, 2023

Market Authorisation Date: 06 December, 2000

Treatment: A method of preventing pregnancy by providing an intrauterine system (ius), holding an inserter handle with one hand, inserting the ius into the uterus, and moving a slider in the handle to release th...

Dosage: INTRAUTERINE DEVICE

More Information on Dosage

MIRENA family patents

Family Patents

4. Skyla patent expiration

SKYLA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5785053 BAYER HLTHCARE Inserter for the positioning of an intrauterine device
Dec, 2015

(8 years ago)

US7252839 BAYER HLTHCARE Delivery system and a manufacturing process of a delivery system
Nov, 2023

(8 months ago)

US11628088 BAYER HLTHCARE Ultrasonically detectable intrauterine system and a method for enhancing ultrasound detection
Feb, 2027

(2 years from now)

US11850182 BAYER HLTHCARE Inserter
Sep, 2029

(5 years from now)

US10561524 BAYER HLTHCARE Inserter
Sep, 2029

(5 years from now)

US9615965 BAYER HLTHCARE Inserter
Sep, 2029

(5 years from now)

US9668912 BAYER HLTHCARE Inserter
Apr, 2031

(6 years from now)

US10987244 BAYER HLTHCARE Inserter
Apr, 2031

(6 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Jan 09, 2016

Market Authorisation Date: 09 January, 2013

Treatment: A method of preventing pregnancy by providing an intrauterine system (ius), holding an inserter handle with one hand, inserting the ius into the uterus, and moving a slider in the handle to release th...

Dosage: INTRAUTERINE DEVICE

More Information on Dosage

SKYLA family patents

Family Patents